My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

by Danielle Bonadies | Dec 29, 2020 | Press Releases

With transformative digital technologies playing an increasingly critical role in health care delivery, the two companies have joined forces on a digital genomic solution that will increase efficiencies and outcomes within the highly specialized space of oncology. NEW...
MMRF CureCloud Study Launches to Democratize Access to Genomic Data in Multiple Myeloma

MMRF CureCloud Study Launches to Democratize Access to Genomic Data in Multiple Myeloma

by Danielle Bonadies | Aug 6, 2020 | News

In an interview with Targeted Oncology, Hearn Jay Cho, MD, PhD, Chief Medical Officer of MMRF and Associate Professor of Hematology and Medical Oncology at Mount Sinai Hospital Ruttenberg Treatment Center and Irene M. Ghobrial, MD, Director of the Clinical...
Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Danielle Bonadies | Jun 1, 2020 | Multimedia

GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion will...
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

by Danielle Bonadies | Feb 6, 2020 | News

Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
Genetic Counselors Share Thoughts on Angelina’s Impact

Genetic Counselors Share Thoughts on Angelina’s Impact

by Danielle Bonadies | May 14, 2018 | Genetic Journal

It’s been five years since Angelina Jolie announced to the world she carries a BRCA1 mutation and had a prophylactic double mastectomy to lower her risks of developing breast cancer. Below genetic counselors reflect on the impact she has made by sharing her...
12Next >

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©